Tuberculosis
General information about Tuberculosis on Beth Israel Deaconess Medical Center's website.
Search Results
Results 371 - 380 of 431
Tuberculosis
General information about Tuberculosis in Spanish on Beth Israel Deaconess Medical Center's website.
BCG Vaccine
General information on the BCG Vaccine on Beth Israel Deaconess Medical Center's website.
Vacuna BCG[BCG Vaccine]
![Vacuna BCG[BCG Vaccine]](/sites/default/files/styles/thumbnail/public/images/publications/ad_334351_0.jpg?itok=3tg8MKzG)
General information on the BCG Vaccine on Beth Israel Deaconess Medical Center's website
Tuberculosis Fármacorresistente: Una Guía Práctica para la Atención Médica del Paciente, 2da Edición[Drug-Resistant Tuberculosis: A Survival Guide for Clinicians]
![Tuberculosis Fármacorresistente: Una Guía Práctica para la Atención Médica del Paciente, 2da Edición[Drug-Resistant Tuberculosis: A Survival Guide for Clinicians]](/sites/default/files/styles/thumbnail/public/images/publications/spanish_mdr_guide_0.jpg?itok=3GCKNxBE)
This manual is a Spanish translation of Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (3rd ed), 2016 by the Curry International Tuberculosis Center. It contains critical information for clinicians taking care of drug-resistant TB patients.
What’s the Role of Fluoroquinolones in the Treatment of TB?: A Look at the Evidence
View this webinar to become familiar with the mechanism of action of Fluoroquinolones, medical trials investigating the role of Fluoroquinolones, and current recommendations and potential future roles of Fluoroquinolones in the treatment of tuberculosis.
DR-TB Drugs Under the Microscope
This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
Roadmap for MDR-TB Scale-up: Increasing Access to MDR-TB Drugs through Innovation and Action
The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.
This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to...
Roadmap for MDR-TB Scale-up: Increasing Access to MDR-TB Drugs through Innovation and Action
The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.
This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to...
Roadmap for MDR-TB Scale-up: Increasing Access to MDR-TB Drugs through Innovation and Action
The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.
This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to...